EPLICANA Trademark

Trademark Overview

On Friday, August 18, 2017, a trademark application was filed for EPLICANA with the United States Patent and Trademark Office. The USPTO has given the EPLICANA trademark a serial number of 87574249. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 15, 2021. This trademark is owned by TAKARA BIO INC.. The EPLICANA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer
eplicana

General Information

Serial Number87574249
Word MarkEPLICANA
Filing DateFriday, August 18, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2017

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 23, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTAKARA BIO INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShiga 525-0058
JP
Party NameTAKARA BIO INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShiga 525-0058
JP

Trademark Events

Event DateEvent Description
Tuesday, February 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2020EXTENSION 5 GRANTED
Friday, June 5, 2020EXTENSION 5 FILED
Tuesday, June 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 5, 2020TEAS EXTENSION RECEIVED
Thursday, December 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019EXTENSION 4 GRANTED
Tuesday, December 3, 2019EXTENSION 4 FILED
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Thursday, June 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 11, 2019EXTENSION 3 GRANTED
Tuesday, June 11, 2019EXTENSION 3 FILED
Tuesday, June 11, 2019TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2018EXTENSION 2 GRANTED
Monday, December 10, 2018EXTENSION 2 FILED
Monday, December 10, 2018TEAS EXTENSION RECEIVED
Thursday, June 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 19, 2018EXTENSION 1 GRANTED
Tuesday, June 19, 2018EXTENSION 1 FILED
Tuesday, June 19, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 29, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 29, 2017ASSIGNED TO EXAMINER
Wednesday, August 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 22, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

eplicana cancer treatment prevention products pharmaceutical